Intraperitoneal microdialysis in the postoperative surveillance after surgery for XXXX : a preliminary report.

@entity1 @entity3166 @entity298 @entity653 @entity880 @entity850 @entity413 @entity2388
BACKGROUND/PURPOSE: The aim of the present pilot study was to evaluate the safety and clinical application of intraperitoneal microdialysis (MD) in preterm @entity1 operated on for @entity3166 ( @entity3166 ). METHODS: Fourteen @entity1 underwent MD. Two were excluded from analysis: 1 because of catheter malfunction and 1 because of fatal outcome immediately after surgery. The median MD time was 122 hours. Samples were collected every 4 hours, and the concentration of @entity413 , @entity880 , @entity2388 , and @entity653 was measured. RESULTS: Three @entity1 were reoperated on: 2 because of recurrent @entity3166 and 1 because of @entity850 . In the 2 cases with recurrent @entity3166 , changes in MD variables were found. Another had a prolonged postoperative period owing to @entity298 . The values of MD normalized along with the return of bowel function. In 8 @entity1 , the postoperative course was uncomplicated. The results of peritoneal MD in @entity1 with complications were significantly different from those with an uncomplicated course ( @entity880 /pyruvate ratio and @entity413 concentration). CONCLUSION: Peritoneal MD is a safe procedure and an applicable method in surveillance of the metabolic and inflammatory changes in the peritoneal cavity after surgery for @entity3166 . Larger series are needed to evaluate the clinical significance and use of this method.
